Investec Switzerland. © Vividrange | Dreamstime.com The value of the Swiss National Bank’s U.S. stock portfolio jumped to a record in June, helped by equity market gains. The holdings climbed to $61.8 billion from $54.5 billion at the end of March, according to calculations by Bloomberg based on the central bank’s regulatory filing to the U.S. Securities and Exchange Commission and published on...
Read More »Switzerland has world’s priciest Big Macs. So eat Swiss chocolate instead.
The Economist invented the Big Mac index in 1986 as a tongue-in-cheek guide to currency valuations. Because the well-known burger is the same throughout much of the world, the magazine thought it could be used as a measure of how over or undervalued a currency was. An overpriced burger suggests an overvalued currency and a cheap one an undervalued currency. As it did last year, Switzerland topped the chart this year...
Read More »Switzerland has world’s priciest Big Macs. So eat Swiss chocolate instead.
The Economist invented the Big Mac index in 1986 as a tongue-in-cheek guide to currency valuations. Because the well-known burger is the same throughout much of the world, the magazine thought it could be used as a measure of how over or undervalued a currency was. An overpriced burger suggests an overvalued currency and a cheap one an undervalued currency. © Mirko Vitali | Dreamstime.com As it did last year, Switzerland topped the chart this year with the world’s most expensive Big Macs. At...
Read More »Swiss stock market rally loses momentum
SMI The Swiss Market Index and global stock markets failed to extend last week’s rally after the Federal Reserve and Bank of Japan left rates unchanged and gave mixed messages about the global economic outlook. Japanese Economic Stimulus Japanese shares received a short-term boost after Prime Minister Shinzo Abe’s announced plans of a 28 trillion yen ($265 billion) economic stimulus drive, including a 13 trillion...
Read More »Swiss stock market rally loses momentum
Investec Switzerland. The Swiss Market Index and global stock markets failed to extend last week’s rally after the Federal Reserve and Bank of Japan left rates unchanged and gave mixed messages about the global economic outlook. © Josefkubes | Dreamstime.com Japanese shares received a short-term boost after Prime Minister Shinzo Abe’s announced plans of a 28 trillion yen ($265 billion) economic stimulus drive, including a 13 trillion yen fiscal spending package for...
Read More »Credit Suisse’s turnaround is working, but vulnerable
Investec Switzerland. Just a month ago, Credit Suisse CEO Tidjane Thiam and Deutsche Bank CEO John Cryan risked, as one hedge fund manager put it, becoming the dead men walking of European banking as they struggled to shore up their firms’ profitability. © Simon Zenger | Dreamstime.com Thursday’s results from Credit Suisse suggest Thiam may escape that fate while Cryan’s effort to revamp the German lender stalls. After a first-quarter loss, the Swiss bank posted a...
Read More »Credit Suisse’s turnaround is working, but vulnerable
Just a month ago, Credit Suisse CEO Tidjane Thiam and Deutsche Bank CEO John Cryan risked, as one hedge fund manager put it, becoming the dead men walking of European banking as they struggled to shore up their firms’ profitability. © Simon Zenger | Dreamstime.com Thursday’s results from Credit Suisse suggest Thiam may escape that fate while Cryan’s effort to revamp the German lender stalls. After a first-quarter...
Read More »Swiss markets fluctuate on earnings data
Investec Switzerland SMI last Week The Swiss Market Index is set to finish the week slightly higher as investors digest second quarter earnings reports and central bank policy announcements. Click to enlarge. Bonds Global financial markets showed resilience this week following the failed coup attempt in Turkey over the weekend. Second quarter earnings proved to be the main drive of sentiment with...
Read More »Roche CEO worried about U.K. drug research following Brexit
Investec Switzerland. The U.K.’s decision to leave the European Union poses a threat to research and development in the pharmaceutical industry, Roche Holding AG Chief Executive Officer Severin Schwan said. © Lucaderoma | Dreamstime.com A departure would mean the country would have to set up its own system for approving drugs for sale, a job now done for bloc members by the European Medicines Agency. That could put U.K. patients at risk of not getting access to medicines as...
Read More »Roche CEO worried about U.K. drug research following Brexit
Investec Switzerland. The U.K.’s decision to leave the European Union poses a threat to research and development in the pharmaceutical industry, Roche Holding AG Chief Executive Officer Severin Schwan said. © Lucaderoma | Dreamstime.com A departure would mean the country would have to set up its own system for approving drugs for sale, a job now done for bloc members by the European Medicines...
Read More »